莱索托家庭HIV检测中当日启动ART与常规转诊对 linkage 和病毒抑制的影响:CASCADE随机临床试验
在莱索托北部农村高HIV流行区,278名家庭HIV检测阳性且未治疗成人随机接受当日家庭ART启动或常规转诊。当日启动组3个月linkage to care率68.6% vs 43.1%,12个月病毒抑制率50.4% vs 34.3%,差异均显著。
要点
- 家庭HIV检测阳性者当日启动ART可显著提高3个月linkage to care率。
- 当日启动ART可显著提高12个月病毒抑制率。
- 该策略在 rural 高流行区可行,支持在家庭检测中提供当日ART。
核心结论
- 在莱索托农村高HIV流行区,与常规转诊相比,家庭HIV检测阳性后当日启动ART显著提高3个月linkage to care和12个月病毒抑制。
研究设计与样本
- 开放标签、两组、随机临床试验,2016年2月22日至2017年9月17日在莱索托北部6家卫生机构开展。
- 在60个农村村庄和17个城市地区的6655户家庭HIV检测中,278名18岁及以上、HIV阳性且未治疗者从268户家庭同意入组。
- 同一家庭个体随机至同一组,当日组n=138,常规组n=140;274人(98.6%)纳入分析。
主要发现
- 3个月linkage to care率:当日组68.6%(94人)vs 常规组43.1%(59人),绝对差异25.6%(95%CI 13.8%至36.3%,P<.001)。
- 12个月病毒抑制率:当日组50.4%(69人)vs 常规组34.3%(47人),绝对差异16.0%(95%CI 4.4%至27.2%,P=.007)。
- 当日组134人(97.8%)表示当天准备启动ART,2人(1.5%)在接下来几天内启动,并获1个月ART供应。
- 当日组报告2例死亡(1.5%),常规组无死亡报告。
关键数值与推荐
- linkage to care定义为家庭访问后90天内到卫生机构就诊。
- 病毒抑制定义为入组后11至14个月病毒载量低于100 copies/mL。
- 常规组转诊至最近卫生机构接受准备咨询后启动ART,此后每月随访。
临床怎么用
- 在家庭HIV检测阳性后,可考虑提供当日家庭ART启动以改善linkage to care和病毒抑制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Home-based HIV testing is a frequently used strategy to increase awareness of HIV status in sub-Saharan Africa. However, with referral to health facilities, less than half of those who test HIV positive link to care and initiate antiretroviral therapy (ART). OBJECTIVE: To determine whether offering same-day home-based ART to patients with HIV improves linkage to care and viral suppression in a rural, high-prevalence setting in sub-Saharan Africa. DESIGN, SETTING, AND PARTICIPANTS: Open-label, 2-group, randomized clinical trial (February 22, 2016-September 17, 2017), involving 6 health care facilities in northern Lesotho. During home-based HIV testing in 6655 households from 60 rural villages and 17 urban areas, 278 individuals aged 18 years or older who tested HIV positive and were ART naive from 268 households consented and enrolled. Individuals from the same household were randomized into the same group. INTERVENTIONS: Participants were randomly assigned to be offered same-day home-based ART initiation (n = 138) and subsequent follow-up intervals of 1.5, 3, 6, 9, and 12 months after treatment initiation at the health facility or to receive usual care (n = 140) with referral to the nearest health facility for preparatory counseling followed by ART initiation and monthly follow-up visits thereafter. MAIN OUTCOMES AND MEASURES: Primary end points were rates of linkage to care within 3 months (presenting at the health facility within 90 days after the home visit) and viral suppression at 12 months, defined as a viral load of less than 100 copies/mL from 11 through 14 months after enrollment. RESULTS: Among 278 randomized individuals (median age, 39 years [interquartile range, 28.0-52.0]; 180 women [65.7%]), 274 (98.6%) were included in the analysis (137 in the same-day group and 137 in the usual care group). In the same-day group, 134 (97.8%) indicated readiness to start ART that day and 2 (1.5%) within the next few days and were given a 1-month supply of ART. At 3 months, 68.6% (94) in same-day group vs 43.1% (59) in usual care group had linked to care (absolute difference, 25.6%; 95% CI, 13.8% to 36.3%; P < .001). At 12 months, 50.4% (69) in the same-day group vs 34.3% (47) in usual care group achieved viral suppression (absolute difference, 16.0%; 4.4%-27.2%; P = .007). Two deaths (1.5%) were reported in the same-day group, none in usual care group. CONCLUSIONS AND RELEVANCE: Among adults in rural Lesotho, a setting of high HIV prevalence, offering same-day home-based ART initiation to individuals who tested positive during home-based HIV testing, compared with usual care and standard clinic referral, significantly increased linkage to care at 3 months and HIV viral suppression at 12 months. These findings support the practice of offering same-day ART initiation during home-based HIV testing. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02692027.
引用
- Labhardt ND, Ringera I, Lejone TI, et al. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial. JAMA. 2018. PMID: 29509839. doi:10.1001/jama.2018.1818
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。